Introduction {#sec1}
============

A higher level of cardiorespiratory fitness, assessed as maximum aerobic capacity (VO~2~max), is associated with lower cardiovascular and total mortality.[@bib1] However direct measurement of peak oxygen consumption by incremental exercise is time consuming, requires appropriate expertise, and is not entirely without risk.[@bib2] Step testing combined with measurement of heart rate is a convenient, safe and inexpensive submaximal test from which VO~2~max can be estimated with acceptable accuracy[@bib3], [@bib4], [@bib5], [@bib6] and precision.[@bib7], [@bib8] Step tests are particularly appropriate for epidemiological work or studies in the home since steps are easily transportable and stepping technique requires little practice.[@bib9]

However, previously validated equations are test specific, with uncertain transferability to other step tests. Further, most currently validated tests have limitations which reduce applicability. For example, the height of the step employed by McArdle et al.[@bib8] is 40 cm, while the Canadian Home Fitness Step Test is an incremental test with two 20 cm steps. These can be challenging tests for an older population, resulting in poor compliance, and multiple steps are cumbersome for home visits. The Tecumseh step test offers advantages in that it is a 3 min step test which employs a single step with a comparatively low height (20 cm) to ensure that measurement of aerobic capacity is not limited by local muscle fatigue.[@bib10], [@bib11] It has been used successfully in children and adults[@bib10], [@bib11]; however, information regarding estimation of VO~2~max using this test is limited[@bib12] and the relationship of VO~2~max estimated by this test to cardiovascular risk factors has not been described. In addition, the rate and extent of heart rate recovery following exercise has been proposed as an indicator of autonomic function[@bib13] and physical fitness[@bib14] and has also been reported to predict future cardiovascular disease and all-cause mortality.[@bib15]

The aim of this study was to compare available equations estimating VO~2~max in the Tecumseh study against a validated equation, to determine heart rate recovery, to evaluate the relationship of these estimates with cardiovascular (CVD) risk factors, and to assess the feasibility of estimation of VO~2~max and measures of heart rate recovery based only on 2 post-exercise measurements of heart rate (30 s and 3 min post-exercise).

Methods {#sec2}
=======

Sample {#sec2.1}
------

The Tecumseh Community Health Study was a longitudinal study of individuals living in Tecumseh, Michigan which commenced in 1957 when all 8800 residents of the 2400 households in Tecumseh were canvassed. Data used in this study were collected over the years 1959--1969 (Round I: 1959--1960, Round II: 1962--1965, and Round III: 1967--1969) and the study achieved a ∼88% response rate.[@bib16] In each of three rounds of data collection interviews and medical examinations were conducted with remaining and new household residents, yielding a total of 11,563 persons who were examined at least once and 4312 who were examined during all three rounds.[@bib17] The current work is based on publically available data for those who undertook step tests in Round II.

Step test {#sec2.2}
---------

For the purpose of this analysis, data were restricted to individuals \>16 y and less than 70 y (*n* = 2286; [Table 1](#tbl1){ref-type="table"}). Exclusion criteria for the step test were: known heart disease or stroke, acute severe respiratory infections, severe arthritis or other orthopaedic disabilities, severe hypertension (\>170 systolic and/or \>110 diastolic) and pregnancy.[@bib10], [@bib11] Approximately 84% of study participants in Round II undertook the step test. The step test was administered in an air-conditioned room (22--24 °C) and consisted of stepping onto an 20 cm (8 inch) bench for 3 min at a rate of 24 steps per min using a metronome. This corresponds to ∼5 times the rate of resting energy metabolism (∼5METS). Heart rates were measured by ECG while the subject was sitting and standing before exercise, during exercise, and at 0.5 1, 2, 3 and 5 min after exercise while the subject was sitting.Table 1Sample demographics and average results.Table 1Variable*N*MeanSDAge, y228635.712.0Male, *N* (%)108648%Height, cm2268168.09.0Weight, kg234969.213.4Body mass index, kg/m^2^220524.63.6Post-load glucose, mg/dl2136132.239.6Systolic blood pressure, mmHg2189129.915.4Diastolic blood pressure, mmHg210185.110.6Total cholesterol, mg/dl2235214.144.4Cigarette smoker, non/current/ex944/1080/24642%/48%/11%VO~2~max(M)22862.330.66VO~2~max(S)22862.790.65VO~2~max(AVD)22372.350.48HRR30, bpm223025.39.2HRR1, bpm160036.611.2HRR2, bpm160941.711.8HRR3, bpm160442.711.3HRRh3, bpm162117.88.3tc~0--3~, s156453.71.6tc~h3~, s162153.52.6[^1]

Other measurements {#sec2.3}
------------------

Participants completed a questionnaire and measurements of height, weight, blood pressure, and blood glucose following a 100 g load (post load glucose (PLG)) and total cholesterol (TC) was performed as previously described.[@bib10], [@bib11], [@bib18] Sitting blood pressure was measured in the right arm by a trained technician using a sphygmomanometer.

Calculation of VO~2~max using submaximal exercise data {#sec2.4}
------------------------------------------------------

An equation relating heart rate following the Tecumseh step test to directly measured peak oxygen consumption (ml/min/kg) based on 100 individuals (52 males, age 18--58 y) was recently reported by Milligan (VO~2~max(M))[@bib12]:$$\text{VO}_{2}\max\left( \text{M} \right)\ \left\lbrack {\text{ml}\ \min^{- 1}\ \text{kg}^{- 1}} \right\rbrack = 84.687-0.722 \cdot \text{HR}_{\text{post}}\ \left\lbrack \text{bpm} \right\rbrack - 0.383 \cdot \text{age}\ \left\lbrack \text{y} \right\rbrack$$where HR~post~ is heart rate 30 s following exercise.

Estimates from this validated equation were compared with peak oxygen consumption (ml/min/kg) estimated by the Astrand/Van Dobeln (AVD) equations:$$\left( \text{Men} \right)\mspace{9mu}\text{VO}_{2}\max\left( \text{AVD} \right) = 1.29 \cdot \sqrt{\frac{\text{Load}\ \left\lbrack {\text{kg}\ \text{m}\ \text{min}^{- 1}} \right\rbrack}{\text{Exercise~heart~rate}\ \left\lbrack \text{bpm} \right\rbrack - 60}} \cdot {\mathbb{e}}^{- 0.0088}$$$$\left( \text{Women} \right)\mspace{9mu}\text{VO}_{2}\text{max}\left( \text{AVD} \right) = 1.18 \cdot \sqrt{\frac{\text{Load}\ \left\lbrack {\text{kg}\ \text{m}\ \text{min}^{- 1}} \right\rbrack}{\text{Exercise~heart~rate}\ \left\lbrack \text{bpm} \right\rbrack - 60}} \cdot {\mathbb{e}}^{- 0.0090}$$where exercise heart rate was the average of the heart rate at 2 min 30 s and 3 min after initiation of exercise. The paper by Van Dobeln et al.[@bib6] only gives parameters for men, so the parameters for women were derived from the data for women given by Astrand.[@bib5]

A further comparison was made with estimates calculated using the equation by Sharkey cited in Refs. [@bib3], [@bib4] which estimates peak oxygen consumption (l/min) as:$$\left( \text{Men} \right)\mspace{9mu}\text{VO}_{2}\max\left( \text{S} \right) = 3.744 \cdot \left( \frac{\text{weight}\ \left\lbrack \text{kg} \right\rbrack + 5}{\max\ \text{pulse}\ \left\lbrack \text{bpm} \right\rbrack - 62} \right)$$$$\left( \text{Women} \right)\mspace{9mu}\text{VO}_{2}\max\left( \text{S} \right) = 3.750 \cdot \left( \frac{\text{weight}\ \left\lbrack \text{kg} \right\rbrack - 3}{\max\ \text{pulse}\ \left\lbrack \text{bpm} \right\rbrack - 65} \right)$$where$$\left( \text{Men} \right)\mspace{9mu}\max\ \text{pulse} = 64.83 + 0.662 \cdot \text{post} - \text{exercise~heart~rate}\ \left\lbrack \text{bpm} \right\rbrack$$$$\left( \text{Women} \right)\mspace{9mu}\max\ \text{pulse} = 51.33 + 0.750 \cdot \text{post} - \text{exercise~heart~rate}\ \left\lbrack \text{bpm} \right\rbrack$$

For the purposes of this comparison VO~2~max(M) calculated by the Milligan equation was multiplied by weight\[kg\]/1000 to estimate peak oxygen consumption in l/min.

Heart rate recovery {#sec2.5}
-------------------

HRR[@bib13] was calculated as the difference between heart rate at the end of exercise and post-exercise recovery heart rate at 30 s (HRR30), 1 min (HRR1), 2 min (HRR2) and 3 min (HRR3). The difference between heart rate at 30 s after exercise and 3 min following the end of exercise (HRRh3) was also calculated. The time constants of the rate of decline in heart rate following cessation of exercise was also calculated by fitting an exponential function of the form$$\text{HR}\left( t \right) = a \cdot {\mathbb{e}}^{- kt} + c$$where HR(*t*) is heart rate at time, *t*, *k* is the rate constant and *a* and *c* are constants. The time constant was estimated as 1/*k*. Time constants were estimated from data collected over the period 0 (end-exercise) to 3 min (*t*~0--3~) and using heart rate measured at 30 s and 3 min (*t*~h3~).

Statistics {#sec2.6}
----------

All statistical analysis was conducted using Stata SE 14.2. Continuous data were summarized as mean (SD) of *N* observations, categorical data as *N* (%). Method comparison was performed using Bland Altman analysis; mean difference and limits of agreement (*d*\[LOA\]) in addition to Lin\'s concordance coefficient, *ρ* (asymptotic 95% confidence interval) were used as summary measures of agreement. Correlation and multiple linear regression was performed to examine bivariate correlations between VO~2~max(M) or measures of heart rate recovery with cardiovascular risk factors (systolic blood pressure (SBP), BMI, PLG and TC). Further multivariable regression was also undertaken: in these models age, sex, education grade, alcohol intake and cigarette smoking were included (chosen *a priori*) as possible confounders. Framingham 10-year cardiovascular risk score (FRS) was calculated as previously described[@bib19] using Ariel Linden\'s Stata module Framingham (<http://www.lindenconsulting.org/stats.html>); however, since high density lipoprotein cholesterol (HDL-C) was not measured in the Tecumseh study, HDL-C values for estimation of FRS were imputed based on age, sex and body mass index (BMI) using regression equations calculated from the Framingham Heart Study dataset. Statistical significance was assigned if *P* \< 0.05.

Results {#sec3}
=======

Demographic characteristics of the sample and results are shown in [Table 1](#tbl1){ref-type="table"}. Mean age of participants was 35.7 (range 16--69 y and 48% were men).

Estimates of VO~2~max {#sec3.1}
---------------------

Bland Altman plots of the estimates of VO~2~max by the different methods are shown in [Fig. 1](#fig1){ref-type="fig"}A and B. VO~2~max(M) and VO~2~max(AVD) (*d* = −0.7 \[−8.9, 7.5\] ml/kg/min and *ρ* = 0.80 (079, 0.81)) showed good agreement with no evidence of bias. Agreement between VO~2~max(M) and VO~2~max(S) (*d* = −0.46 \[−2.02, 1.10\] l/min and *ρ* = 0.21 (0.17, 0.24)) was poor.Figure 1Bland Altman plots for comparison of estimated maximum oxygen consumption using A) Milligan equation (VO~2~max(M)) vs. Astrand/Van Dobeln equations (VO~2~max(AVD)), B) Milligan equation (VO~2~max(M)) vs. Sharkey equation (VO~2max~(S)). Dashed line indicates the mean difference and the short dashed lines indicate the limits of agreement.Figure 1

Correlations and multivariable associations between estimated VO~2~max and risk factors {#sec3.2}
---------------------------------------------------------------------------------------

Correlations between VO~2~max(M) and CVD risk factors, including FRS, are shown in [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"}. VO~2~max(M) was significantly inversely correlated with each of the individual risk factors and showed a stronger inverse correlation with FRS. In a multivariable model including the same variables plus potential confounders (age sex, and cigarette smoking, education grade and alcohol intake) SBP, BMI and PLG were significantly inversely associated with VO~2~max(M) in addition to the anticipated inverse relationships with age, sex and current smoking.Table 2Correlations between VO~2~max(M), ml/min/kg and systolic blood pressure, body mass index, post-load glucose, total cholesterol and Framingham coronary heart disease risk score.Table 2VO~2~max(M)SBPBMIPLGTCSBP**−0.24**BMI**−0.240.36**PLG**−0.270.180.13**TC**−0.310.190.250.15**FRS^a^**−0.520.480.340.280.56**[^2]Table 3A multivariate model of the association of maximum oxygen consumption (VO~2~max(M)) with risk factors.Table 3Beta coefficientAdjusted *R*-squared = 0.4295% CI*P* valueAge, y−0.4−0.4−0.3\<0.001Female sex−4.6−5.3−4.0\<0.001Smoking Current−1.7−2.4−1.0\<0.001 Ex−0.5−1.50.40.3Alcohol, Oz/week−0.002−0.0060.0020.3Education grade−0.1−0.30.00.1Systolic BP, mmHg−0.05−0.07−0.03\<0.001BMI, kg/m^2^−0.26−0.35−0.17\<0.001Post-load glucose, mg/dl−0.01−0.02−0.01\<0.001Total cholesterol, mg/dl−0.004−0.0110.0030.3Constant66.563.169.8\<0.001[^3]

Correlation and agreement between estimates of HRR and time constants of heart rate recovery {#sec3.3}
--------------------------------------------------------------------------------------------

Heart rates at rest, standing, and throughout exercise and recovery are shown in [Fig. 2](#fig2){ref-type="fig"}. Heart rate recovered to resting levels by ∼2--3 min. HRR30, HRR1, HRR2 and HRR3 were strongly correlated, however there was an inverse correlation between HRR30 and HRRh3, a weak correlation between HRR1 and HRRh3, and between HRRh3 and HRR2, and a moderate correlation between HRRh3 and HRR3 ([Table 4](#tbl4){ref-type="table"}A). Agreement was good between *t*~0--3~ and *t*~h3~ (*d* = 0.2 \[−3.0, 3.4\]; *ρ* = 0.72 (0.70, 0.74)) and both time constants were closely positively correlated to one another and inversely correlated with HRR1, HRR2, HRR3 and HRRh3 ([Table 4](#tbl4){ref-type="table"}A).Figure 2Box plot of heart rate before, during and after exercise. Abbreviations: Sit, sitting; Stand, standing prior to exercise; Ex230, 2 min 30 s of exercise; Ex3, 3 min of exercise; Post30, 30 s post-exercise; Post1, 1 min post-exercise; Post2, 2 min post-exercise; Post3, 3 min post-exercise; Post5, 5 min post-exercise.Figure 2Table 4A) Correlations between measures of heart rate recovery. B) Correlations between measures of heart rate recovery and risk factors.Table 4HRR30HRR1HRR2HRR3HRRh3tc~0--3~HRR1**0.79**HRR2**0.710.82**HRR3**0.700.780.85**HRRh3**−0.170.190.380.59**tc~0--3~**−0.48−0.61−0.79−0.86−0.64**tc~h3~0.05**−0.26−0.42−0.63−0.940.80**HRR30HRR1HRR2HRR3HRRh3tc~0--3~tc~h3~SBP**−0.18−0.16−0.14−0.14**0.02**0.13**0.02BMI**−0.18−0.15−0.10**−0.08**0.11**0.05−0.08PLG**−0.14−0.13−0.12−0.10**^a^0.02**0.11**0.02TC**−0.20−0.16−0.14−0.10**0.070.06−0.06[^4]

Correlation between measures of heart rate recovery and CVD risk factors {#sec3.4}
------------------------------------------------------------------------

HRR30, HRR1, HRR2 and HRR3 correlated inversely with SBP, BMI, PLG and total cholesterol ([Table 4](#tbl4){ref-type="table"}B); correlations, although significant, were weak and tended to be stronger for HRR30 and progressively less strong for HRR1, HRR2 and HRR3. HRRh3 only correlated positively with BMI and not with other risk factors. *t*~0--3~ correlated positively, albeit weakly, with SBP and PLG whereas no significant correlations were observed between *t*~h3~ and CVD risk factors. Multivariate modelling showed that negative associations between age and magnitude of heart rate recovery at various times and higher heart rate recovery in women were fairly consistent across the different measures. Negative associations between current smoking or BMI and HRR30 were progressively attenuated in measurements based on longer durations (HRR1, HRR2 and HRR3), while the association between BMI and HRRh3 reversed to become positive ([Supplementary Tables S1--S5](#appsec1){ref-type="sec"}). Similarly, in multivariable models, shorter time constants of heart rate recovery in women were observed using both *t*~0--3~ and *t*~h3.~ However, associations between current smoking, SBP and PLG and slower time of recovery, which were evident using *t*~0--3,~ were weaker and not significant for *t*~h3~ ([Supplementary Tables S6 and S7](#appsec1){ref-type="sec"}).

Discussion {#sec4}
==========

This study demonstrates that estimates of VO~2~max derived from a Tecumseh step test, using a validated equation, agree closely with those estimated by the Astrand/Van Dobeln equations,[@bib5], [@bib6] but considerably less well with estimates based on the equation formulated by Sharkey and used by Marley and Linnerud.[@bib3] The poorer agreement with this latter equation may result from its failure to account for age, since the relationship between heart rate and maximum oxygen consumption is known to decline with age.[@bib5], [@bib6], [@bib20] The equation described by Milligan[@bib12] has the advantage that it has been validated against maximal exercise determinations of aerobic capacity, however its limitation is that it assumes the decline in VO~2~max with age is similar in both sexes. There is evidence that this is not the case[@bib5], [@bib6], [@bib20] and this is incorporated into the Astrand/Van Dobeln equations. Nevertheless, the relatively close agreement between VO~2~max(M) and VO~2~max(AVD) suggests that both these equations probably provide acceptable estimates of VO~2~max within the recognized limits of estimation of aerobic capacity by submaximal exercise.[@bib21], [@bib22]

We further show that VO~2~max estimated by the validated Milligan equation is inversely correlated with systolic BP, BMI, higher glucose following a 100 g oral glucose load, serum cholesterol and FRS, a risk score that combines many of these individual risk factors and hence may account for risk factor clustering. In a multivariable model incorporating the individual risk factors, systolic BP, BMI, higher glucose following a 100 g oral glucose load were independently associated with VO~2~max. Similar associations were seen with VO~2~max estimated using the Astrand/Van Dobeln equations (data not shown). These findings are consistent with previous studies that used maximal exercise testing to determine VO~2~max,[@bib23], [@bib24] and a study that used a submaximal step test, the Canadian Aerobic Fitness Test.[@bib25] In that study correlations between estimated VO~2~max and blood pressure, lipids, and BMI were of a similar magnitude to those reported here.

Estimates of HRR were reasonably correlated, except when it was calculated as the difference between heart rate at 30 s after exercise and 3 min following the end of exercise (HRRh3). This estimate only showed a moderate correlation with the other measures. The time constants of decline in heart rate after exercise correlated with one another more closely. The comparatively rapid decline in heart rate in the first minute of recovery is believed to be largely attributable to withdrawal of vagal tone, whereas the slower decline in heart rate over the subsequent 2--4 min is considered to reflect a combination of reduced vagal and sympathetic tone.[@bib13] Correlations between measures of heart rate recovery and CVD risk factors, although significant and in the anticipated direction were weak. Further, our data suggest that HRRh3 is not a useful measure of heart rate recovery. Similarly, although tc~0--3~ and tc~h3~ correlate quite closely with one another, tc~h3~ appears to be too imprecise a measure of the time course of heart rate recovery to be particularly useful in identifying weak associations with risk factors.

Although only resting blood pressure was measured in this study, a possible additional utility of this step test is that it can be used to determine the blood pressure response to sub-maximal exercise.[@bib26] Blood pressure measured after moderate exercise of similar intensity to that used here has been shown to be associated with target organ damage[@bib27] and to have prognostic significance independent of resting blood pressure.[@bib28]

This study has strengths and weaknesses: it uses data from a large community-based sample of men and women, with minimal exclusions except for safety considerations, and covers a large age range enhancing its generalizability. However, the data were collected in the 1960s and there are no corresponding direct measurements of VO~2~max available, and measurements of CVD risk factors are limited. The sample was almost exclusively White Americans and our observations cannot necessarily be extrapolated to other ethnic groups. The data are cross-sectional and therefore should not be interpreted as demonstrating causal links between factors.

In summary, a Tecumseh step test can be used to provide valid estimates of VO~2~max using at least two equations, and can be used to measure heart rate recovery. Estimated VO~2~max was inversely associated with higher systolic BP, higher BMI and worse glucose tolerance. Measurement of heart rate recovery over the first 30 s and the time constant calculated over the entire first 3 min of recovery correlate most closely with CVD risk factors and are therefore the preferred outcome measure of this test.
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[^1]: Abbreviations: HRR30, heart rate recovery at 30 s; HRR1, heart rate recovery at 1 min; HRR2, heart rate recovery at 2 min; HRR3, heart rate recovery at 3 min; HRRh3, heart rate recovery between 30 s and 3 min; SD, standard deviation; tc~0--3~, time constant of heart rate recovery over 0--3 min post exercise; tc~h3~, time constant of heart rate recovery estimated from heart rate at 30 s and 3 min; VO~2~max(M), estimated maximal oxygen consumption using Milligan equation; VO~2~max(S), estimated maximal oxygen consumption using Sharkey equation; VO~2~max(AVD), estimated maximal oxygen consumption using Astrand/Van Dobeln equations. Missing variables account for the different *N*\'s. Post-load glucose values were restricted to those receiving 100 g glucose.

[^2]: Abbreviations: BMI, body mass index; FRS, Framingham coronary heart disease risk score, PLG, post-load glucose; SBP, systolic blood pressure; TC, total cholesterol; VO~2~max(M), estimated maximal oxygen consumption using Milligan equation. Data are Pearson\'s (or ^a^Spearman\'s) correlation coefficients, values in bold indicate *P* \< 0.001. All *P* values were calculated using a Bonferroni correction for multiple testing.

[^3]: Abbreviations: 95% CI, 95% confidence interval; BMI, body mass index; SBP, systolic blood pressure.

[^4]: Abbreviations: BMI, body mass index; HRR30, heart rate recovery at 30 s; HRR1, heart rate recovery at 1 min; HRR2, heart rate recovery at 2 min; HRR3, heart rate recovery at 3 min; HRRh3, heart rate recovery between 30 s and 3 min; PLG, post-load glucose; SBP, systolic blood pressure; TC, total cholesterol; tc~0--3~, time constant of heart rate recovery over 0--3 min post exercise; tc~h3~, time constant of heart rate recovery estimated from heart rate at 30 s and 3 min. Data are Pearson\'s correlation coefficients, values in bold indicate *P* \< 0.001, except ^a^*P* \< 0.01. All *P* values were calculated using a Bonferroni correction for multiple testing.
